MyDay MiSight 1 Day reaches Asia Pacific in latest global expansion

CooperVision has expanded the global availability of its MyDay® MiSight® 1 day contact lenses, with immediate launches in Australia and New Zealand, marking the product’s first entry into the Asia Pacific region. The lenses are also now shipping in South Africa and Israel, following an earlier rollout across Europe, the Middle East, and Africa.

The company said the expansions support its goal of making evidence-based myopia management accessible to eye care professionals and children worldwide. “Myopia is a pressing health challenge of epic proportions, now affecting nearly one in three children worldwide,” said Debbie Olive, chief commercial officer for CooperVision, in the release. “The growing availability and adoption of our myopia control contact lenses, including MyDay MiSight 1 day, are helping drive a meaningful shift in pediatric eye care by supporting children's vision today while helping protect their sight for the future.”

The lenses combine MiSight 1 day ActivControl® Technology with the silicone hydrogel material used in MyDay lenses, providing daily disposable comfort alongside “always-on” myopia control. The technology has shown an approximate 50% reduction in myopia progression and is supported by the longest-running soft contact lens clinical trial for myopia control in children.

“The introduction of MyDay MiSight 1 day into the Asia Pacific region marks an important milestone in our global efforts to make the latest in evidence-based myopia control accessible to as many children as possible,” said Jennifer Lambert, vice president of Myopia Control and Cornea Care for CooperVision, in the release. The company said it plans to continue phased expansion in additional Asia Pacific markets in the coming months.